Concepedia
Statistics
Publications
6
Citations
757
H-Index
Active since
2011
Affiliations
Oxagen (United Kingdom)(Current)
University of Oxford
L. Pearce Collins is an author at Oxagen (United Kingdom) specializing in pharmacotherapy, immunology, and pharmacology.
Publications per year
2011–2014
A randomized, double‐blind, placebo‐controlled study of the CRTH2 antagonist OC000459 in moderate persistent asthma
N. Barnes, Ian Pavord, John I. Bell et al. · Clinical & Experimental Allergy · 2011 · 217 citations · Full text
Pharmacy, Pharmacology, Pharmacotherapy +14
Anti‐eosinophil activity and clinical efficacy of the <scp>CRTH</scp>2 antagonist <scp>OC</scp>000459 in eosinophilic esophagitis
Alex Straumann, Ch. Bussmann, M. Stuck et al. · Allergy · 2013 · 207 citations
Life Sciences, Immunology, Pharmacology +10
Heightened response of eosinophilic asthmatic patients to the <scp>CRTH</scp>2 antagonist <scp>OC</scp>000459
Roy Pettipher, Michael Hunter, Christopher Perkins et al. · Allergy · 2014 · 133 citations
Pharmacy, Pharmacology, Pharmacotherapy +15
Inhibition of the asthmatic allergen challenge response by the CRTH2 antagonist OC000459
Paul Cadden, Michael Hunter, L. Pearce Collins et al. · European Respiratory Journal · 2012 · 103 citations · Full text
Medicine, Immunology, Pharmacology +16
The <scp>CRTH</scp>2 antagonist <scp>OC</scp>000459 reduces nasal and ocular symptoms in allergic subjects exposed to grass pollen, a randomised, placebo‐controlled, double‐blind trial
Friedrich Horak, Petra Zieglmayer, René Zieglmayer et al. · Allergy · 2012 · 85 citations
Life Sciences, Immunology, Pharmacotherapy +17
1–5 of 6